According to Lumos Pharma's latest financial reports the company's current EPS (TTM) is -$7.62. In 2022 the company made an earnings per share (EPS) of -$7.48 a decrease over its 2021 EPS that were of -$5.84.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$7.08 | -5.37% |
2022 | -$7.48 | 27.98% |
2021 | -$5.84 | 305.62% |
2020 | -$1.44 | -90.26% |
2019 | -$14.80 | -29.48% |
2018 | -$20.98 | -38.72% |
2017 | -$34.24 | -20.07% |
2016 | -$42.83 | 111.51% |
2015 | -$20.25 | -137.77% |
2014 | $53.61 | -396.77% |
2013 | -$18.07 | 10.71% |
2012 | -$16.32 | 6.4% |
2011 | -$15.33 |